Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating safety and efficacy of YRA-1909 in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• YRA-1909

Snippet

Sponsor: Yungjin Pharm. Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED